SOPHiA Genetics SA Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
32.3%projected annual EPS growth
Analyst Coverage
4analysts covering
FY Revenue (est.)
$93.4Mnext fiscal year
FY EPS (est.)
-$0.78next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Q3 2026 Earnings Release and Conference Call | 4 Nov 2026 |
| Q4 and Full Year 2026 Earnings Release | 2 Mar 2027 |
Monitoring Framework
Key Performance Indicators
SOPHiA DDM Platform Analyses Volume Quarterly108KTarget: Continued volume growth driven by U.S. health system integrations
Net Dollar Retention (NDR) Quarterly117.0Target: Maintain strong expansion within existing customer base
Adjusted Gross Margin Quarterly7,540.0%Target: Approach long-term target through cloud compute optimization
Core Genomics Customers Quarterly537Target: Expand global footprint with new hospital and laboratory accounts
Watch Items
- Leadership Transition ExecutionTrigger: Ross Muken assuming CEO role on July 1, 2026, and Dr. Jurgi Camblong transitioning to Chairman of the BoardAction: Monitor strategic continuity, organizational alignment, and execution of the U.S. commercial strategy under new leadership.
- Path to Adjusted EBITDA ProfitabilityTrigger: Approaching adjusted EBITDA breakeven by the end of 2026 and crossing over to positive adjusted EBITDA in H2 2027Action: Track operating leverage, headcount management, and cost-control measures implemented in Q2 2026.
- U.S. Market Expansion and Health System IntegrationsTrigger: Onboarding of major integrated health systems expected to add 60,000 analyses annuallyAction: Verify implementation timelines, volume ramp-up, and corresponding revenue contribution from U.S. clinical customers.
- Capital Deployment and DilutionTrigger: Utilization of $57.5 million gross proceeds raised in the June 2026 public offeringAction: Evaluate the allocation of capital toward platform development, joint ventures (e.g., MSK joint venture), and its impact on cash runway.
Research as of 20 Jun 2026